Loading market dashboard
Entrada Therapeutics, Inc.
TRDAHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Entrada Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $214.60M | $18.97M - $577.46M | $53.15M | -$1.691 | 2 |
| Dec 2029 | $83.70M | $7.40M - $225.24M | $20.73M | -$2.68 | 2 |
| Dec 2028 | $55.28M | $4.89M - $148.77M | $13.69M | -$3.362 | 5 |
| Dec 2027 | $29.19M | $3.82M - $54.56M | $7.23M | -$3.58 | 5 |
| Dec 2026 | $19.51M | $977.5K - $55.54M | $4.83M | -$3.962 | 6 |
| Dec 2025 | $30.45M | $29.54M - $31.88M | $7.54M | -$3.606 | 5 |
| Dec 2024 | $186.52M | $184.74M - $189.23M | $46.20M | $1.053 | 5 |
| Dec 2023 | $239.40M | $21.16M - $644.19M | $59.30M | $3.11 | 2 |
| Dec 2022 | $43.43M | $32.02M - $70.31M | $28.13M | -$3.063 | 2 |